enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
0.9458
-0.0222 (-2.29%)
At close: Oct 6, 2025, 4:00 PM EDT
0.9588
+0.0130 (1.37%)
After-hours: Oct 6, 2025, 5:13 PM EDT
enVVeno Medical Market Cap
enVVeno Medical has a market cap or net worth of $18.20 million as of October 6, 2025. Its market cap has decreased by -73.20% in one year.
Market Cap
18.20M
Enterprise Value
-16.06M
1-Year Change
-73.20%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since May 31, 2018, enVVeno Medical's market cap has decreased from $40.00M to $18.20M, a decrease of -54.49%. That is a compound annual growth rate of -10.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 18.63M | -64.82% |
| Dec 31, 2024 | 52.96M | -22.63% |
| Dec 29, 2023 | 68.45M | 41.69% |
| Dec 30, 2022 | 48.31M | -22.58% |
| Dec 31, 2021 | 62.40M | 222.87% |
| Dec 31, 2020 | 19.33M | 96.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |